RGFP 966
Chemical Name: (2E)-N-(2-Amino-4-fluorophenyl)-3-[1-(3-phenyl-2-propen-1-yl)-1H-pyrazol-4-yl]-2-propenamide
Purity: ≥98%
Biological Activity
RGFP 966 is a potent and selective HDAC3 inhibitor (IC50 = 80 nM); exhibits no effect on other HDAC (up to 15 μM). RGFP 966 reduces the frequency of striatal CAG repeat expansions in mouse models of Huntington's disease and reduces mHTT accumulation. RGFP 966 blocks the formation of reactive astrocytes and, in vivo, it is neuroprotective and enhances long-term object-location memory.Technical Data
The technical data provided above is for guidance only.
For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Background References
-
HDAC3-selective inhibitor enhances extinction of cocaine-seeking behavior in a persistent manner.
Malvaez et al.
Proc.Natl.Acad.Sci.USA., 2013;110:2647
Product Datasheets
Citation for RGFP 966
The citations listed below are publications that use Tocris products. Selected citations for RGFP 966 include:
1 Citation: Showing 1 - 1
-
NF-κB-dependent repression of Sox18 transcription factor requires the epigenetic regulators histone deacetylases 1 and 2 in acute lung injury.
Authors: Ting Et al.
Front Physiol 2022;13:947537
FAQs
No product specific FAQs exist for this product, however you may
View all Small Molecule FAQsReviews for RGFP 966
There are currently no reviews for this product. Be the first to review RGFP 966 and earn rewards!
Have you used RGFP 966?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image